GB Patent
GB201613828D0 — Therapeutic agents for lysosomal storage disorders
Assigned to Intrabio Ltd · Expires 2016-09-28 · 10y expired
What this patent protects
Patent listed against Aqneursa.
Drugs covered by this patent
- Aqneursa (LEVACETYLLEUCINE) · Intrabio
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.